Cargando…
Minimal Invasive Abdominal Sacral Colpopexy and Abdominal Lateral Suspension: A Prospective, Open-Label, Multicenter, Non-Inferiority Trial
Background: Abdominal minimally invasive surgery has become increasingly prominent for the treatment of prolapse. Abdominal sacral colpopexy (ASC) is the gold standard for the treatment of advanced apical prolapse; however, alternative surgical approaches such as the abdominal lateral suspension (AL...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147058/ https://www.ncbi.nlm.nih.gov/pubmed/37109262 http://dx.doi.org/10.3390/jcm12082926 |
_version_ | 1785034725315837952 |
---|---|
author | Russo, Eleonora Montt Guevara, Maria Magdalena Sacinti, Koray Gorkem Misasi, Giulia Falcone, Maria Morganti, Riccardo Mereu, Liliana Dalprà, Francesca Tateo, Saverio Simoncini, Tommaso |
author_facet | Russo, Eleonora Montt Guevara, Maria Magdalena Sacinti, Koray Gorkem Misasi, Giulia Falcone, Maria Morganti, Riccardo Mereu, Liliana Dalprà, Francesca Tateo, Saverio Simoncini, Tommaso |
author_sort | Russo, Eleonora |
collection | PubMed |
description | Background: Abdominal minimally invasive surgery has become increasingly prominent for the treatment of prolapse. Abdominal sacral colpopexy (ASC) is the gold standard for the treatment of advanced apical prolapse; however, alternative surgical approaches such as the abdominal lateral suspension (ALS) have been developed to improve patient outcomes. This study aims to determine whether ALS improves outcomes compared to ASC in multicompartmental prolapse patients. Methods: A prospective, open-label, multicenter, non-inferiority trial was conducted in 360 patients who underwent ASC or ALS for the treatment of apical prolapse. The primary outcome was anatomical and symptomatic cure of the apical compartment at 1-year follow-up; secondary outcomes included prolapse recurrence, re-operation rate, and post-operative complications. A 300-patient cohort was subdivided into 200-patients who underwent ALS and 100-patients who underwent ASC. The confidence interval method was used to calculate the p-value of non-inferiority. Results: At the 12-months follow-up, the objective cure rate of the apical defect was 92% for ALS and 94% for ASC (recurrence rates were 8% and 6%, respectively, and the p-value for non-inferiority was <0.01). The mMesh complication rates were 1% and 2% for ALS and ASC, respectively. Conclusions: This study demonstrated that the ALS technique is not inferior to the gold standard ASC for the surgical treatment of apical prolapse. |
format | Online Article Text |
id | pubmed-10147058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101470582023-04-29 Minimal Invasive Abdominal Sacral Colpopexy and Abdominal Lateral Suspension: A Prospective, Open-Label, Multicenter, Non-Inferiority Trial Russo, Eleonora Montt Guevara, Maria Magdalena Sacinti, Koray Gorkem Misasi, Giulia Falcone, Maria Morganti, Riccardo Mereu, Liliana Dalprà, Francesca Tateo, Saverio Simoncini, Tommaso J Clin Med Article Background: Abdominal minimally invasive surgery has become increasingly prominent for the treatment of prolapse. Abdominal sacral colpopexy (ASC) is the gold standard for the treatment of advanced apical prolapse; however, alternative surgical approaches such as the abdominal lateral suspension (ALS) have been developed to improve patient outcomes. This study aims to determine whether ALS improves outcomes compared to ASC in multicompartmental prolapse patients. Methods: A prospective, open-label, multicenter, non-inferiority trial was conducted in 360 patients who underwent ASC or ALS for the treatment of apical prolapse. The primary outcome was anatomical and symptomatic cure of the apical compartment at 1-year follow-up; secondary outcomes included prolapse recurrence, re-operation rate, and post-operative complications. A 300-patient cohort was subdivided into 200-patients who underwent ALS and 100-patients who underwent ASC. The confidence interval method was used to calculate the p-value of non-inferiority. Results: At the 12-months follow-up, the objective cure rate of the apical defect was 92% for ALS and 94% for ASC (recurrence rates were 8% and 6%, respectively, and the p-value for non-inferiority was <0.01). The mMesh complication rates were 1% and 2% for ALS and ASC, respectively. Conclusions: This study demonstrated that the ALS technique is not inferior to the gold standard ASC for the surgical treatment of apical prolapse. MDPI 2023-04-18 /pmc/articles/PMC10147058/ /pubmed/37109262 http://dx.doi.org/10.3390/jcm12082926 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Russo, Eleonora Montt Guevara, Maria Magdalena Sacinti, Koray Gorkem Misasi, Giulia Falcone, Maria Morganti, Riccardo Mereu, Liliana Dalprà, Francesca Tateo, Saverio Simoncini, Tommaso Minimal Invasive Abdominal Sacral Colpopexy and Abdominal Lateral Suspension: A Prospective, Open-Label, Multicenter, Non-Inferiority Trial |
title | Minimal Invasive Abdominal Sacral Colpopexy and Abdominal Lateral Suspension: A Prospective, Open-Label, Multicenter, Non-Inferiority Trial |
title_full | Minimal Invasive Abdominal Sacral Colpopexy and Abdominal Lateral Suspension: A Prospective, Open-Label, Multicenter, Non-Inferiority Trial |
title_fullStr | Minimal Invasive Abdominal Sacral Colpopexy and Abdominal Lateral Suspension: A Prospective, Open-Label, Multicenter, Non-Inferiority Trial |
title_full_unstemmed | Minimal Invasive Abdominal Sacral Colpopexy and Abdominal Lateral Suspension: A Prospective, Open-Label, Multicenter, Non-Inferiority Trial |
title_short | Minimal Invasive Abdominal Sacral Colpopexy and Abdominal Lateral Suspension: A Prospective, Open-Label, Multicenter, Non-Inferiority Trial |
title_sort | minimal invasive abdominal sacral colpopexy and abdominal lateral suspension: a prospective, open-label, multicenter, non-inferiority trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147058/ https://www.ncbi.nlm.nih.gov/pubmed/37109262 http://dx.doi.org/10.3390/jcm12082926 |
work_keys_str_mv | AT russoeleonora minimalinvasiveabdominalsacralcolpopexyandabdominallateralsuspensionaprospectiveopenlabelmulticenternoninferioritytrial AT monttguevaramariamagdalena minimalinvasiveabdominalsacralcolpopexyandabdominallateralsuspensionaprospectiveopenlabelmulticenternoninferioritytrial AT sacintikoraygorkem minimalinvasiveabdominalsacralcolpopexyandabdominallateralsuspensionaprospectiveopenlabelmulticenternoninferioritytrial AT misasigiulia minimalinvasiveabdominalsacralcolpopexyandabdominallateralsuspensionaprospectiveopenlabelmulticenternoninferioritytrial AT falconemaria minimalinvasiveabdominalsacralcolpopexyandabdominallateralsuspensionaprospectiveopenlabelmulticenternoninferioritytrial AT morgantiriccardo minimalinvasiveabdominalsacralcolpopexyandabdominallateralsuspensionaprospectiveopenlabelmulticenternoninferioritytrial AT mereuliliana minimalinvasiveabdominalsacralcolpopexyandabdominallateralsuspensionaprospectiveopenlabelmulticenternoninferioritytrial AT dalprafrancesca minimalinvasiveabdominalsacralcolpopexyandabdominallateralsuspensionaprospectiveopenlabelmulticenternoninferioritytrial AT tateosaverio minimalinvasiveabdominalsacralcolpopexyandabdominallateralsuspensionaprospectiveopenlabelmulticenternoninferioritytrial AT simoncinitommaso minimalinvasiveabdominalsacralcolpopexyandabdominallateralsuspensionaprospectiveopenlabelmulticenternoninferioritytrial |